02816nas a2200265 4500000000100000008004100001653003500042653002500077653001600102653002500118653003900143100001100182700001200193700001100205700001300216700001400229700001200243700001300255700001000268245012100278856005600399300000900455490000600464520208000470 2016 d10amass drug administration (MDA)10aCommunity acceptance10aElimination10aLymphatic filariasis10aNeglected tropical diseases (NTDs)1 aSaha S1 aMiah KA1 aAlam A1 aHaque HS1 aSultana S1 aHaque N1 aPasha MK1 aDas T00aOperational issues of lymphatic filariasis elimination program and community acceptance of mass drug administration. uhttp://cimch.edu.bd/resources/journal/Article-2.pdf a7-110 v13 a
Introduction: Lymphatic Filariasis (LF) is a Neglected Tropical Disease (NTD). Mass Drug Administration (MDA) is the recommended preventive chemotherapy by the World Health Organization (WHO) to stop the spread of infection. But proper execution of the program is yet to be confirmed. Methods: This cross-sectional study was conducted in Rangpur district among the permanent residents and health officers. Concurrent mixed method approach was taken for data collection. Purposively 204 respondents were selected for quantitative data. Qualitative data were collected through focus group discussions of the residents of that area and in-depth interviews were taken from the health officers as key informants. Results: Among all the respondents, 98.5% was found to be aware of LF, 83.4% was found to be aware of MDA whereas only about 55% of the respondents found to have ingested drugs given during last MDA round. Majority came to know about LF through neighbor/friends or seeing a patient, and Mass Drug Distributors were source of information for MDA in majority of sampled population. Majority related purpose of MDA with antihelminthic drug distribution and vitamin supplementation, along with prevention of LF. Among those who were aware of MDA, 15.7% knew about the correct dose of their age group. Urban area was recorded lower rates of drug ingestion than rural area. At the health system and policy level, lack of workforce, poor planning-promotionadvocacy, delay in supply and processes, inappropriate strategy and poor community participation were prominent at various stages of program implementation. Addition of fixed-site drug distribution in urban area, intensified health education and advocacy programs, more community participation of local governments and more allocation of workforce is essential for better program implementation. Conclusion: Baseline survey and community participation with proper monitoring were essential for the best outcome of the LF elimination program.